Tvardi Therapeutics Inc.

NASDAQ: TVRD · Real-Time Price · USD
24.30
0.51 (2.14%)
At close: Aug 15, 2025, 3:59 PM
24.00
-1.23%
After-hours: Aug 15, 2025, 04:10 PM EDT

Tvardi Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
7.14M n/a n/a 23.03M
Cost of Revenue
812K n/a n/a 1.55M
Gross Profit
6.33M n/a n/a 21.47M
Operating Income
-55.78M -18.66M -21.19M -89.08M
Interest Income
2.83M 1.32M 654K 603K
Pretax Income
-71.27M -17.35M -20.54M -88.44M
Net Income
-70.87M -17.35M -20.54M -88.44M
Selling & General & Admin
26.39M 2.8M 2.73M 27.98M
Research & Development
32.76M 15.87M 18.47M 82.58M
Other Expenses
2.96M n/a n/a n/a
Operating Expenses
62.11M 18.66M 21.19M 110.56M
Interest Expense
8.47M n/a 3K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
62.92M 18.66M 21.19M 112.11M
Income Tax Expense
-398K n/a n/a n/a
Shares Outstanding (Basic)
1.52M 9.36M 9.36M 1.41M
Shares Outstanding (Diluted)
1.52M 9.36M 9.36M 1.41M
EPS (Basic)
-46.59 -1.85 -2.2 -62.77
EPS (Diluted)
-46.59 -1.85 -2.2 -62.77
EBITDA
-62.6M -17.25M -20.45M -86.89M
EBIT
-62.79M -17.35M -20.54M -88.44M
Depreciation & Amortization
192K 95K 85K 1.55M